Drug Treatments Archives - Page 2 of 12

Summary:
10 therapeutic agents are in active clinical trials. Another 15 therapeutic agents are in planning stages. Currently the three (3) most likely drugs to be safe and effective are, for critically ill COVID-19 patients: (1) Remdesivir anti-viral drug by Gilead, and (2) Actemra/RoActemra (Tocilizumab) immunosuppressive drug by Roche, and for early stage SARS-CoV-2 infection: (3) Avigan (favipiravir) anti-viral drug by Fujifilm, Japan.
Published for educational purposes and social benefit, not for profit. Not a recommendation or endorsement. Always consult your doctor for medical advice.

July 2020

BBC NEWS | Coronavirus: Protein [Interferon beta] treatment trial ‘a breakthrough’

sibiu1182020-07-21T05:02:20+00:00July 20th, 2020|

The preliminary results of a clinical trial suggest a new treatment for Covid-19 dramatically reduces the number of patients needing intensive care, according to the UK company that developed it. [...]

Pharmacology Research | Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study

sibiu1182020-07-12T07:13:31+00:00July 12th, 2020|

Our objective was to explore the effects of the administration of anti-platelet therapy on arterial oxygenation and clinical outcomes in patients with severe Covid-19 with hypercoagulability... The effects might be [...]

PRESS RELEASE | Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID-19

sibiu1182020-07-12T07:48:28+00:00July 11th, 2020|

Gilead says remdesivir coronavirus treatment reduces risk of death [62%] in severely sick patients - CNBC -- Data Presented Includes a Comparative Analysis of Clinical Recovery and Mortality Outcomes from [...]

PRESS RELEASE | Regeneron Announces Start of REGN-COV2 Phase 3 COVID-19 Prevention Trial in Collaboration with National Institute of Allergy and Infectious Diseases (NIAID) Anti-viral antibody cocktail REGN-COV2 is also in Phase 2/3 treatment trials following positive Phase 1 safety review

sibiu1182020-07-12T08:38:11+00:00July 6th, 2020|

Reprinted for educational purposes and social benefit, not for profit. NEWS PROVIDED BY Regeneron Pharmaceuticals, Inc. Jul 06, 2020, 07:00 ET ClinicalTrials.gov Identifier: NCT04452318 TARRYTOWN, N.Y., July 6, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, [...]

WHO | ACT-Accelerator Investment Case

sibiu1182020-07-03T11:49:23+00:00July 3rd, 2020|

ACT-Accelerator Investment Case

June 2020

THE GUARDIAN | US buys up world stock of key Covid-19 drug No other country will be able to buy remdesivir, which can help recovery from Covid-19, for next three months at least

sibiu1182020-06-30T19:54:46+00:00June 30th, 2020|

The US has bought up virtually all the stocks for the next three months of one of the two drugs proven to work against Covid-19, leaving none for the UK, [...]

JOHNS HOPKINS 2019 Novel Coronavirus Research Compendium (NCRC)

sibiu1182020-06-28T03:54:06+00:00June 28th, 2020|

https://ncrc.jhsph.edu/ Our teams rapidly curate and assess emerging research on SARS-CoV-2 and COVID-19. We prioritize original, high-quality research for public health action and papers receiving significant attention, regardless of quality. [...]

CNN | After saving his own life with a repurposed drug, a professor reviews every drug being tried against Covid-19. Here’s what he’s found

sibiu1182020-06-27T14:04:11+00:00June 27th, 2020|

(CNN) Every morning, Dr. David Fajgenbaum takes three life-saving pills. He wakes up his 21-month-old daughter Amelia to help feed her. He usually grabs some Greek yogurt to eat quickly [...]

PENN | News Release | Taking Inventory of Which Drugs the World Is Using to Treat COVID-19

sibiu1182020-06-27T13:46:57+00:00June 27th, 2020|

Penn researchers create database to categorize off-label use and look for promising leads May 27, 2020 Source: Penn Medicine News Reprinted for educational purposes and social benefit, not for [...]

CORONA (COvid19 Registry of Off-label & New Agents)

sibiu1182020-06-27T14:10:25+00:00June 27th, 2020|

https://cdcn.org/corona/ CORONA (COvid19 Registry of Off-label & New Agents) Drug Repurposing for COVID-19 Our overarching vision: A world where data on all treatments that have been used against COVID19 are maintained in a central repository [...]